JP2009524829A5 - - Google Patents

Download PDF

Info

Publication number
JP2009524829A5
JP2009524829A5 JP2008552490A JP2008552490A JP2009524829A5 JP 2009524829 A5 JP2009524829 A5 JP 2009524829A5 JP 2008552490 A JP2008552490 A JP 2008552490A JP 2008552490 A JP2008552490 A JP 2008552490A JP 2009524829 A5 JP2009524829 A5 JP 2009524829A5
Authority
JP
Japan
Prior art keywords
biomarker
test sample
amount
ivf
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008552490A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009524829A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/002456 external-priority patent/WO2007089734A2/en
Publication of JP2009524829A publication Critical patent/JP2009524829A/ja
Publication of JP2009524829A5 publication Critical patent/JP2009524829A5/ja
Pending legal-status Critical Current

Links

JP2008552490A 2006-01-27 2007-01-29 ヒトｉｖｆ由来胚のプロテオームフィンガープリンティング：発生能のバイオマーカーの同定法 Pending JP2009524829A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76249206P 2006-01-27 2006-01-27
PCT/US2007/002456 WO2007089734A2 (en) 2006-01-27 2007-01-29 Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential

Publications (2)

Publication Number Publication Date
JP2009524829A JP2009524829A (ja) 2009-07-02
JP2009524829A5 true JP2009524829A5 (enExample) 2010-03-25

Family

ID=38327982

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008552490A Pending JP2009524829A (ja) 2006-01-27 2007-01-29 ヒトｉｖｆ由来胚のプロテオームフィンガープリンティング：発生能のバイオマーカーの同定法

Country Status (6)

Country Link
US (1) US20090215085A1 (enExample)
EP (1) EP1994408A4 (enExample)
JP (1) JP2009524829A (enExample)
AU (1) AU2007209980A1 (enExample)
CA (1) CA2640614A1 (enExample)
WO (1) WO2007089734A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006007560A2 (en) 2004-07-01 2006-01-19 University Of Pennsylvania Targeted protein replacement for the treatment of lysosomal storage disorders
US20090075293A1 (en) * 2007-09-07 2009-03-19 Pevsner Paul H Methods for predicting embryo viability
WO2009075862A1 (en) * 2007-12-11 2009-06-18 New York University School Of Medicine Method of assessing viability of embryos in vitro
US10350277B2 (en) 2011-09-07 2019-07-16 Icahn School Of Medicine At Mount Sinai Ceramidase and cell differentiation
RU2474823C1 (ru) * 2011-09-26 2013-02-10 Федеральное государственное бюджетное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования качества эмбрионов в программе экстракорпорального оплодотворения
ES2786128T3 (es) 2012-06-01 2020-10-08 Icahn School Med Mount Sinai Niveles de ceramida en el tratamiento y prevención de infecciones
JP6832158B2 (ja) 2013-03-14 2021-02-24 アイカーン スクール オブ メディシン アット マウント サイナイ 治療用酸性セラミダーゼ組成物ならびにそれを作製および使用する方法
CN107003319B (zh) * 2014-09-24 2019-12-31 曼普知识产权控股有限公司 提供妊娠预测的方法
CN111279421B (zh) * 2017-09-29 2024-04-09 布里格姆妇女医院 人类胚胎的自动评价
JP7134462B2 (ja) * 2018-03-28 2022-09-12 国立大学法人 大分大学 胚の評価方法
RU2706683C1 (ru) * 2019-06-05 2019-11-20 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ прогнозирования готовности эндометрия к успешной имплантации эмбриона у женщин с маточной формой бесплодия с использованием компьютерной морфометрии
CA3144694A1 (en) * 2019-07-25 2021-01-28 Jose A. Horcajadas Identification of viable human embryos

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462454B (sv) * 1988-11-10 1990-06-25 Pharmacia Ab Maetyta foer anvaendning i biosensorer
US6283761B1 (en) * 1992-09-08 2001-09-04 Raymond Anthony Joao Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
PT700521E (pt) * 1993-05-28 2003-10-31 Baylor College Medicine Metodo e espectrometro de massa para dessorcao e ionizacao de analitos
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US5994148A (en) * 1997-06-23 1999-11-30 The Regents Of University Of California Method of predicting and enhancing success of IVF/ET pregnancy
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
CN1169188C (zh) * 1999-04-29 2004-09-29 赛弗根生物系统股份有限公司 具有憎水覆层的气相质谱仪样品支架
ATE313799T1 (de) * 1999-09-27 2006-01-15 Clifford L Librach Nachweis von hla-g
WO2002006829A2 (en) * 2000-07-18 2002-01-24 Correlogic Systems, Inc. A process for discriminating between biological states based on hidden patterns from biological data
US7113896B2 (en) * 2001-05-11 2006-09-26 Zhen Zhang System and methods for processing biological expression data
US7541003B2 (en) * 2001-07-17 2009-06-02 Bio-Rad Laboratories, Inc. Latex based adsorbent chip
US20020193950A1 (en) * 2002-02-25 2002-12-19 Gavin Edward J. Method for analyzing mass spectra
JP2005526972A (ja) * 2002-05-02 2005-09-08 シファーゲン バイオシステムズ， インコーポレイテッド 多糖系ヒドロゲルをコーティングした表面を有するバイオチップ
EP1552302B1 (en) * 2002-07-24 2009-03-25 Bio-Rad Laboratories, Inc. Protein interaction difference mapping
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US7572601B2 (en) * 2004-10-15 2009-08-11 Northwestern University Compositions and methods for determining oocyte development potential

Similar Documents

Publication Publication Date Title
WO2011072177A3 (en) Biomarker assay for diagnosis and classification of cardiovascular disease
WO2009037659A3 (en) Magnetic detection of small entities
NO20083820L (no) Deteksjon av kreft ved forhoyede nivaer av BCL-2
EP2667195A3 (en) Ratio based biomarkers and methods of use thereof
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
WO2010092164A3 (en) Bacterial dna as markers of cardiovascular and/or metabolic disease
NO20083461L (no) Genekspresjonsmarkorer for kolorektal cancer-prognose
WO2010062960A3 (en) METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
WO2009129505A3 (en) Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
JP2010506147A5 (enExample)
JP2016507233A5 (enExample)
EP2021794B8 (en) Use of protein s100a 12 as a marker for colorectal cancer
BRPI0812771A2 (pt) Método para a detecção e diagnóstico in vitro de uma infecção por um microorganismo, conjunto de reagentes para a realização do método de detecção .
JP2013503617A5 (enExample)
WO2011021041A3 (en) Survival prognostic assay
JP2010528620A5 (enExample)
WO2011087709A3 (en) Eml4-alk translocations in lung cancer
WO2007089734A3 (en) Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential
JP2011518338A5 (enExample)
BRPI0807690A2 (pt) Tira de teste e medidor de analito de analito e método de produção de tira de teste com lanceta integrada.
JP2009515556A5 (enExample)
WO2008138928A3 (en) Diagnostic of immune graft tolerance
EP2350318A4 (en) METHOD, COMPOSITIONS AND KITS FOR DIAGNOSIS, MONITORING AND TREATING DISEASES
BR112013005977A2 (pt) polipeptídeo isolado, anticorpo contra efrina-b2 e sua utilização, ácido nucleíco; vetor; célula; método de obtenção do polipeptídeo ou do anticorpo; método de detecção e/ou quantificação da efrina-b2; método de diagnóstico de uma enfermidade associada a expressão da efrina-b2; composição e sua utilização
WO2006131537A3 (en) Methods for the diagnosis of immune graft tolerance